HIMS & HERS HEALTH INC
HIMSNYSETrading Snapshot
- Day Range
- $469.40 β $482.20
- 52-Week Range
- $13.74 β $65.30
- Volume
- $5.47B
- Avg Volume
- $6.71B
- Shares Outstanding
- 223.1M
- Next Earnings
- Dec 4, 2026
Fundamentals Snapshot
- Annual Revenue
- $2.35B
- Last Q Revenue
- $753M
- P/E Ratio
- -47.2
- P/S Ratio
- 2.5x
- EPS (TTM)
- $-0.61
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +3.1%
Why Investors Own HIMS
- βHigh-growth profile β revenue up +34.2% YoY with expanding US Equity exposure.
- βHealthy economics β 31% gross margin and 28% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
HIMS & HERS HEALTH INC
HIMSAbout HIMS & HERS HEALTH INC
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates
HIMS & HERS HEALTH INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift HIMS price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
HIMS & HERS HEALTH INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.